PERCEPTIVE ADVISORS LLC - 10 Jun 2026 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: SLDB
Reported as of: 10 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Jun 2026, 16:05:22 UTC
Prior SEC filing: 10 Jul 2026
Next SEC filing: 15 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Joseph Edelman - for Perceptive Advisors LLC, By: Joseph Edelman, its managing member

Key filing fact

PERCEPTIVE ADVISORS LLC filed Form 4 for Solid Biosciences Inc. (SLDB) on 11 Jun 2026.

Key facts

This page summarizes PERCEPTIVE ADVISORS LLC's Form 4 filing for Solid Biosciences Inc. (SLDB).
1 reported transaction and 3 derivative rows are listed below.
Accepted by SEC: 11 Jun 2026, 16:05.

Change

Previous filing in this sequence was filed on 10 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (3)

CIK 0001224962 Primary reporting owner

PERCEPTIVE ADVISORS LLC

Relationship: Director, 10%+ Owner
Address: 51 ASTOR PLACE, 10TH FLOOR, NEW YORK
Signature: /s/ Joseph Edelman - for Perceptive Advisors LLC, By: Joseph Edelman, its managing member
Signature date: 11 Jun 2026

CIK 0001164426

EDELMAN JOSEPH

Relationship: Director, 10%+ Owner
Address: 51 ASTOR PLACE, 10TH FLOOR, NEW YORK
Signature: /s/ Joseph Edelman - for Perceptive Life Sciences Master Fund Ltd., By: Perceptive Advisors LLC, its investment manager, By: Joseph Edelman, its managing member
Signature date: 11 Jun 2026

CIK 0001249675

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

Relationship: Director, 10%+ Owner
Address: 51 ASTOR PLACE, 10TH FLOOR, NEW YORK
Signature: /s/ Joseph Edelman
Signature date: 11 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SLDB transaction Derivative

Director Stock Option (Right to Buy)

Award

Transaction value
Shares: +77,500
Change %
Price: $0.000000^*
Shares after: 77,500
Date: 10 Jun 2026
Ownership: See footnote
Underlying class: Common Stock
Underlying amount: 77,500
Exercise price: $6.61
Footnotes: F1, F2, F3

SLDB transaction Derivative

Director Stock Option (Right to Buy)

Award

Transaction value
Shares: +77,500
Change %
Price: $0.000000^*
Shares after: 77,500
Date: 10 Jun 2026
Ownership: See footnote
Underlying class: Common Stock
Underlying amount: 77,500
Exercise price: $6.61
Footnotes: F1, F2, F3

SLDB transaction Derivative

Director Stock Option (Right to Buy)

Award

Transaction value
Shares: +77,500
Change %
Price: $0.000000^*
Shares after: 77,500
Date: 10 Jun 2026
Ownership: See footnote
Underlying class: Common Stock
Underlying amount: 77,500
Exercise price: $6.61
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

This option was granted on June 10, 2026 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

Footnote F2

Consists of options to purchase shares of the Issuer's common stock awarded to Adam Stone in connection with his role as a member of the Issuer's Board of Directors. Mr. Stone is the Chief Investment Officer of Perceptive Advisors, LLC (the "Advisor"). The Advisor may be deemed to have an indirect pecuniary interest in the options to purchase common stock of the Issuer reported herein because the Advisor has the right to receive the director compensation provided in respect of Mr. Stone's board service through a partial management fee offset.

Footnote F3

Joseph Edelman is the managing member of the Advisor. The Advisor serves as the investment manager to Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Each of Mr. Edelman, the Advisor and the Master Fund disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that Mr. Edelman, the Advisor or the Master Fund is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.